Topiramate Capsule
Product Images NDC 67877-868

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 67877-868). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi-spnk-1 (Topi Spnk 1)

Chemical structure diagram of the active ingredient Topiramate, showing its molecular arrangement including oxygen, sulfur, nitrogen atoms, and methyl groups.*

FDA Label Image

Topi-spnk-2 (Topi Spnk 2)

A bar chart showing the change from baseline to double-blind phase in average monthly migraine rate for Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day compared to placebo. Two studies are represented with different bar shading, indicating decreased migraine rates with increasing Topiramate doses, with statistical significance noted at various dose levels.*

FDA Label Image

Topi-spnk-3 (Topi Spnk 3)

A cumulative event curve chart comparing the rates over time to first seizure for two Topiramate dosages, 50 mg/day and 400 mg/day. The x-axis represents time in days up to 500, and the y-axis shows cumulative rates from 0.00 to 0.50. The chart includes number of participants for each dose group and a p-value indicating statistical comparison.*

FDA Label Image

Topi-spnk-4-a (Topi Spnk 4 A)

Label for Topiramate Capsules, USP 15 mg, oral capsules by Ascend Laboratories, LLC. The label indicates a package size of 500 capsules and includes storage instructions to keep at 20°C to 25°C, with permitted excursions. The label contains the NDC number 67877-868-05 and advises dispensing the Medication Guide to each patient. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ.*

FDA Label Image

Topi-spnk-5-a (Topi Spnk 5 A)

Label for Topiramate Capsules USP 25 mg from Ascend Laboratories, LLC. The label shows NDC 67877-869-05, indicates 500 capsules, and provides storage instructions between 20°C to 25°C with excursions allowed up to 30°C. It also includes a pharmacist dispensing note and manufacturer information.*

FDA Label Image

Topi-spnk-6-a (Topi Spnk 6 A)

Topiramate 15 mg Capsules, USP label for a prescription drug product by Ascend Laboratories, LLC. The label includes dosage and storage instructions, a barcode, quantity of 60 capsules, and manufacturer information (Alkem Laboratories Ltd., India). The label specifies pharmacist instructions and cautions to keep out of reach of children.*

FDA Label Image

Topi-spnk-7-a (Topi Spnk 7 A)

Label for Topiramate Capsules, USP 25 mg by Ascend Laboratories, LLC. The label includes the NDC number 67877-869-60 and states the package contains 60 capsules. It provides storage instructions, cautions, and manufacturer and distributor details, with specific mention of dispensing medication guides to patients. A barcode is also visible on the right side.*

FDA Label Image

Topi-spnk-8-a (Topi Spnk 8 A)

Carton label for Topiramate Capsules, USP 15 mg by Ascend Laboratories, LLC. The label states it is for oral use, prescription only, containing a carton of 10 capsules. It includes storage instructions, manufacturer information (Alkem Laboratories Ltd., India), and a barcode. The dosage strength 15 mg per capsule is prominently displayed.*

FDA Label Image

Topi-spnk-9-a (Topi Spnk 9 A)

Packaging label for Topiramate Capsules, USP 25 mg oral capsules. The carton contains 10 unit-dose capsules and is labeled for prescription use only. The product is distributed by Ascend Laboratories, LLC and manufactured by Alkem Laboratories Ltd., India. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.